Zinc-thymulin complex (Zn-FTS) binds thymulin receptor on T-lymphocytes, promoting T-cell differentiation and maturation. Without zinc, biologically inactive. Anti-inflammatory: potent inhibitor of pro-inflammatory cytokines. Analgesic: central and peripheral mechanisms via opioid and GABA systems in rodent models.
Studies have administered: Research doses: 10ng–10mcg in animal models; human dosing not well established
Dardenne group (Pasteur Institute): immune restoration in aged and immunocompromised animals. Pain studies: gene therapy and intranasal delivery show potent analgesic effects equal to morphine without addiction potential in rodents. Human data limited but immunological activity confirmed.
Very limited human data; generally considered safe at physiological concentrations; zinc toxicity concerns at high doses only
These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.
Want a Complete Research Monograph?
Our AI can generate a 2,000+ word deep-dive on Thymulin (Facteur Thymique Sérique) — including full clinical trial summaries, pharmacokinetics, and research frontiers.
Generate Deep Dive in Research Chat